Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tina A. Ayeni"'
Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma
Autor:
Sean C. Dowdy, Andrea Mariani, Amy L. Weaver, Gary L. Keeney, Mariam M. AlHilli, Jamie N. Bakkum-Gamez, Karl C. Podratz, Janice R. Martin, Tina A. Ayeni, Michaela E. McGree
Publikováno v:
Gynecologic Oncology. 128:71-76
Abdominal peritoneal implants are characteristic of uterine serous carcinoma (USC). The presumed mechanism of dissemination is retrograde transit via the fallopian tube. We assessed the impact of tubal ligation (TL) on the metastatic profile and surv
Autor:
Carrie L. Langstraat, Qing Zhang, Eati Basal, Tina A. Ayeni, E. Leof, Patricia K. Donahoe, Xueqian Yin, David Pépin, William A. Cliby
Publikováno v:
Current molecular medicine. 16(3)
The MIS pathway is a potential therapeutic target in epithelial ovarian cancer (EOC): signaling requires both type II (T2R) and type I receptors (T1R), and results in growth inhibition. MISR2 is expressed in EOC, but the prevalence and relative contr
Autor:
Victoria L. Bae-Jump, Laura J. Havrilesky, Angeles Alvarez Secord, Brian Calingaert, Tina A. Ayeni, Daniel L. Clarke-Pearson, Andrew Berchuck, Paola A. Gehrig
Publikováno v:
Gynecologic Oncology. 105:677-682
Objective. The optimal management of patients with stage I uterine papillary serous carcinoma (UPSC) is unclear. We sought to determine whether outcomes of women with surgical stage I UPSC differ with and without adjuvant therapy. Methods. Retrospect
Autor:
Mariam M. AlHilli, Jamie N. Bakkum-Gamez, Andrea Mariani, Gary L. Keeney, Amy L. Weaver, Sean C. Dowdy, Michaela E. McGree, William A. Cliby, Karl C. Podratz, Tina A. Ayeni
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 25(1)
ObjectiveMinimally invasive surgery (MIS) is the preferred technique for managing endometrial cancer. Given that uterine serous carcinoma (USC) has a predilection for multiquadrant peritoneal dissemination, our objective was to estimate the potential
Autor:
Jennifer M. Rubatt, Lisa A. Grace, Andrew Berchuck, Mark D. Starr, Susan K. Murphy, Tina A. Ayeni, William T. Barry, David J. Adams, Angeles Alvarez Secord, Deanna Teoh
Purpose To explore the activity of dasatinib alone and in combination with paclitaxel and carboplatin in ovarian cancer cells and to determine if dasatinib activity can be predicted based on evaluation of the SRC pathway. Experimental design Microarr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d007d29d2af63d0ed4262bf0abfb1c9
https://europepmc.org/articles/PMC3062679/
https://europepmc.org/articles/PMC3062679/
Publikováno v:
SPIE Proceedings.
Kawasaki Disease is an inflammatory illness of young children that can seriously affect the cardiovascular system. The disease may cause coronary artery aneurysms, a thinning and dilation of the arterial wall when the wall is weakened by disease. Suc
Autor:
Jamie N. Bakkum-Gamez, Amy L. Weaver, M. Al Hilli, Tina A. Ayeni, Karl C. Podratz, Janice R. Martin, Michaela E. McGree, G. Keeney, Andrea Mariani, Sean C. Dowdy
Publikováno v:
Gynecologic Oncology. 127:S6
Publikováno v:
Gynecologic Oncology. 125:S111
Autor:
Karl C. Podratz, Andrea Mariani, Amy L. Weaver, William A. Cliby, Michaela E. McGree, M. Al Hilli, Sean C. Dowdy, Tina A. Ayeni
Publikováno v:
Gynecologic Oncology. 120:S86
Autor:
William J. Sullivan, Ed Leof, Tina A. Ayeni, Maryanne Edens, William A. Cliby, Carrie L. Langstraat
Publikováno v:
Cancer Research. 70:1586-1586
Objective: Mullerian inhibiting substance type II receptor (MISRII) is a tissue-specific target for therapy in gynecologic cancers. MISRII plays a specialized role in regression of the mullerian tracts embryologically. Analogous to other TGF-β famil